Journal SAM: Risk Assessment and Predictive Value of Coronary Artery Disease Testing
Release Date: 7/1/2012
Expiration Date: 7/1/2016
Continuing Education Credit Information
ABNM SAM Credit
The American Board of Nuclear Medicine has reviewed and approved this Journal SAM activity submitted by the SNMMI. This activity fulfills the requirements of the ABNM Maintenance of Certification program for self-assessment. 1.5 SAMs have been awarded for this activity.
The Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
SNMMI designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM.
Upon completion of this module, participants will be able to:
1. Describe the concordance and discordance of myocardial ischemia and anatomic coronary artery disease.
2. Comprehend the expected cardiac event rates on the basis of the extent and severity of myocardial perfusion abnormalities.
3. Report the expected 1-year event rates on the basis of the extent and severity of anatomic coronary artery disease visualized by coronary CT angiography.
4. Restate the clinical value of serial testing for evaluation of the ischemic burden in patients with stable ischemic heart disease.
The LLSAP is designed for all nuclear medicine specialists and other physicians, pharmacists and technologists who practice diagnostic and/or therapeutic nuclear medicine.
In accordance with ACCME Revised Standards for Commercial Support and SNM Conflict-of-Interest Policy, the author has indicated no relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.